About this trial
The goal of this clinical trial is to learn if the "Mittin" intervention can improve women's ability to manage their fertility in line with their preferences among women aged 15-49 using hormonal contraceptives or intrauterine devices and attending public health centers in Addis Ababa, Ethiopia. The main question it aims to answer is: Does the Mittin intervention increase preference-aligned fertility management, contraceptive method satisfaction, and preferred contraceptive method use among participants compared to standard care?
Researchers will compare women's outcomes in health centers providing the Mittin intervention to women's outcomes in health centers that offer standard care to see if Mittin improves women's ability to act in line with their contraceptive preferences.
Participants will
* Receive either standard contraception services (control arm) or enhanced services (intervention arm) * Participate in a survey at the beginning of the study * Participate in surveys 4 and 8 months later
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Woman
Started or continued using hormonal contraceptive method or copper IUD on day of recruitment
Ages 15-49 years
Willing to provide phone number and receive follow-up phone call
Disqualifiers
Not planning to live in Addis Ababa for the next eight months
Can not verbally communicate
Not willing to provide consent for the study
Trial design
Parallel
Treatments tested in this trial
Mittin
BehavioralMittin intervention consists of the following components: 1. Educational posters and handouts to raise awareness of the right to contraceptive choice and to switch methods if side effects become intolerable 2. Decision support tools for providers to aid women in weighing the risks and benefits of potential side effects during in-person counseling 3. On-demand and proactive virtual side effects counseling and referrals via a call center.
Treatment groups
Trial outcomes
Primary outcomes
Preference-Aligned Fertility Management (PFM) Index
The PFM Index measures whether use or non-use of contraception aligns with one's preferences. It is a binary measure where 0=no alignment, and 1=alignment.
Secondary outcomes
Agency in Contraceptive Decisions Scale
This 15-item scale includes individual items scored on a scale 0-3. The composite score is an average of scores on all items. 3=highest agency.
Method satisfaction
1-item measure where 1=very dissatisfied and 5=very satisfied
Preferred Method Use
Single item assesses whether there is a contraceptive method that a person would like to use but is not currently using (Yes/No/Uncertain)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, San Francisco
Lead sponsor
St. Paul's Hospital Millennium Medical College, Ethiopia
Collaborator
Bill and Melinda Gates Foundation
Collaborator